Research Project
Project Title: |
Study of Sparsentan in Patients With Primary Focal Segmental Glomerulosclerosis (FSGS) (DUPLEX) |
Project Type: |
Clinical Trial, Enrolment ongoing Adjunct biobank: DNA, Serum, Plasma, Urine |
Disease group(s): |
Immune glomerulopathies |
Project Summary: |
To determine the long-term nephroprotective potential of treatment with sparsentan as compared to an angiotensin receptor blocker in patients with primary and genetic focal segmental glomerulosclerosis (FSGS). |
Lead principal investigator(s): |
Giovanni Montini, Milan Bertrand Knebelmann, Paris |
Co-investigator(s): |
Myriam Dao, Paris |
Project Period: |
03/2018 - 12/2022 |
Sponsors: |
Industry |
ClinicalTrials.gov: |
NCT03493685 |
EudraCT Nr.: |
2016-005141-23 |
« Back to research page